Should hormone therapy be recommended for prevention of cardiovascular disease?
作者信息
Roberts Helen, Hickey Martha
机构信息
Department of Obstetrics and Gynaecology, University of Auckland, New Zealand.
出版信息
Cochrane Database Syst Rev. 2015 Mar 12;2015(3):ED000097. doi: 10.1002/14651858.ED000097.
Abstract
摘要
相似文献
1
Should hormone therapy be recommended for prevention of cardiovascular disease?是否应该推荐激素疗法来预防心血管疾病？
Cochrane Database Syst Rev. 2015 Mar 12;2015(3):ED000097. doi: 10.1002/14651858.ED000097.
2
Menopausal hormone therapy for the prevention of cardiovascular disease: Evidence-based customization.用于预防心血管疾病的绝经激素治疗：基于证据的个体化方案
Maturitas. 2015 Aug;81(4):421-2. doi: 10.1016/j.maturitas.2015.05.001. Epub 2015 May 7.
3
[Can postmenopausal hormone replacement therapy decrease the risk of cardiovascular disease?].绝经后激素替代疗法能否降低心血管疾病风险？
Praxis (Bern 1994). 1999 Sep 2;88(36):1439-42.
4
Menopause and hormone therapy: from vascular endothelial function to cardiovascular disease.更年期与激素疗法：从血管内皮功能到心血管疾病
Hellenic J Cardiol. 2009 Jul-Aug;50(4):303-15.
5
Menopausal hormone therapy for the primary prevention of chronic conditions.用于慢性病一级预防的绝经激素治疗
Am Fam Physician. 2013 Mar 15;87(6):437-8.
6
The Kronos Early Estrogen Prevention Study by Charlotte Barker.夏洛特·巴克主持的克罗诺斯早期雌激素预防研究。
Womens Health (Lond). 2013 Jan;9(1):9-11. doi: 10.2217/whe.12.69.
7
[New insights on the effects of hormone replacement therapy on the breast tissue and the orgnaism].
Wien Klin Wochenschr. 2003;115 Suppl 2:46-9.
8
Hormone therapy for preventing cardiovascular disease in post-menopausal women.激素疗法预防绝经后女性心血管疾病
Cochrane Database Syst Rev. 2015 Mar 10;2015(3):CD002229. doi: 10.1002/14651858.CD002229.pub4.
9
Randomized clinical trials of hormone replacement therapy for treatment or prevention of cardiovascular disease: a review of the findings.
Atherosclerosis. 2003 Feb;166(2):203-12. doi: 10.1016/s0021-9150(02)00202-2.
10
Notes From Cardiology Clinic: Woman, Lost During Follow-up.心脏病诊所记录：女性，随访期间失访。
Can J Cardiol. 2019 Nov;35(11):1435-1436. doi: 10.1016/j.cjca.2019.05.010. Epub 2019 May 14.
本文引用的文献
1
Hormone therapy for preventing cardiovascular disease in post-menopausal women.激素疗法预防绝经后女性心血管疾病
Cochrane Database Syst Rev. 2015 Mar 10;2015(3):CD002229. doi: 10.1002/14651858.CD002229.pub4.
2
Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.近期绝经女性的动脉成像结果和心血管危险因素：一项随机试验。
Ann Intern Med. 2014 Aug 19;161(4):249-60. doi: 10.7326/M14-0353.
3
Oophorectomy, estrogen, and dementia: a 2014 update.卵巢切除术、雌激素与痴呆症：2014年最新进展
Mol Cell Endocrinol. 2014 May 25;389(1-2):7-12. doi: 10.1016/j.mce.2014.01.020. Epub 2014 Feb 5.
4
Mood disorders in midlife women: understanding the critical window and its clinical implications.中年女性的情绪障碍：了解关键时期及其临床意义。
Menopause. 2014 Feb;21(2):198-206. doi: 10.1097/GME.0000000000000193.
5
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.绝经激素治疗与妇女健康倡议随机试验干预和停药后扩展阶段的健康结局。
JAMA. 2013 Oct 2;310(13):1353-68. doi: 10.1001/jama.2013.278040.
6
Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies.激素治疗与认知的关键窗口期假说：临床研究的科学更新。
Menopause. 2013 Jun;20(6):695-709. doi: 10.1097/GME.0b013e3182960cf8.
7
Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future.绝经后激素治疗的时间假说：起源、现状和未来。
Menopause. 2013 Mar;20(3):342-53. doi: 10.1097/GME.0b013e3182843aad.
8
Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.从绝经激素治疗的妇女健康倡议试验中吸取的教训。
Obstet Gynecol. 2013 Jan;121(1):172-6. doi: 10.1097/aog.0b013e31827a08c8.
9
Hormone replacement therapy.激素替代疗法。
BMJ. 2012 Feb 16;344:e763. doi: 10.1136/bmj.e763.
10
Hormones and heart disease in women: the timing hypothesis.女性激素与心脏病：时机假说
Am J Epidemiol. 2007 Sep 1;166(5):506-10. doi: 10.1093/aje/kwm214.
Zotero 插件